{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:10:04Z","timestamp":1793949004564,"version":"4.8.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01253-8","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:17:16Z","timestamp":1778523436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Applications of Thermoresponsive Hydrogels for Sustained Drug Release in Ocular and Intravitreal Formulations Treating Visual Impairments"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5808-314X","authenticated-orcid":false,"given":"Bayan","family":"Alshahrouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-4503","authenticated-orcid":false,"given":"Benjamin E.","family":"Blass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-9593","authenticated-orcid":false,"given":"Thomas","family":"D\u00fcrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6952-7017","authenticated-orcid":false,"given":"Reza","family":"Fassihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"1253_CR1","unstructured":"Ghebreyesus TA. World report on vision. Geneva: World Health Organization, License: CC BY-NC-SA 3.0 IGO. 2019. https:\/\/www.who.int\/publications\/i\/item\/9789241516570"},{"key":"1253_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1442-9071.2010.02363.x","volume":"38","author":"CE Willoughby","year":"2010","unstructured":"Willoughby CE, Ponzin D, Ferrari S, Lobo A, Landau K, Omidi Y. Anatomy and physiology of the human eye: effects of mucopolysaccharidoses disease on structure and function - a review. Clin Exp Ophthalmol. 2010;38:2\u201311.","journal-title":"Clin Exp Ophthalmol"},{"key":"1253_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092830","volume":"19","author":"CH Tsai","year":"2018","unstructured":"Tsai CH, Wang PY, Lin IC, Huang H, Liu GS, Tseng CL. Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. Int J Mol Sci. 2018;19:2830.","journal-title":"Int J Mol Sci"},{"key":"1253_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","volume":"321","author":"C Jumelle","year":"2020","unstructured":"Jumelle C, Gholizadeh S, Annabi N, Dana R. Advances and limitations of drug delivery systems formulated as eye drops. J Control Release. 2020;321:1\u201322.","journal-title":"J Control Release"},{"key":"1253_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1124\/jpet.119.256933","volume":"370","author":"V Gote","year":"2019","unstructured":"Gote V, Sikder S, Sicotte J, Pal D. Ocular drug delivery: present innovations and future challenges. J Pharmacol Exp Ther. 2019;370:602\u201324.","journal-title":"J Pharmacol Exp Ther"},{"key":"1253_CR6","doi-asserted-by":"publisher","unstructured":"Truong D, Wu KY, Nguyen L, Tran SD. Advancements in hydrogel technology for ocular drug delivery. 2024.\u00a0https:\/\/doi.org\/10.37349\/ebmx.2024.00023.","DOI":"10.37349\/ebmx.2024.00023"},{"key":"1253_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12:348\u201360.","journal-title":"AAPS J"},{"key":"1253_CR8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","volume":"58","author":"A Urtti","year":"2006","unstructured":"Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58:1131\u20135.","journal-title":"Adv Drug Deliv Rev"},{"key":"1253_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","volume":"13","author":"EM del Amo","year":"2008","unstructured":"del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today. 2008;13:135\u201343.","journal-title":"Drug Discov Today"},{"key":"1253_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2:47\u201364.","journal-title":"World J Pharmacol"},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4155\/tde-2020-0114","volume":"12","author":"H Shoukat","year":"2021","unstructured":"Shoukat H, Buksh K, Noreen S, Pervaiz F, Maqbool I. Hydrogels as potential drug-delivery systems: network design and applications. Ther Deliv. 2021;12:375\u201396.","journal-title":"Ther Deliv"},{"key":"1253_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118803","volume":"573","author":"S Cascone","year":"2020","unstructured":"Cascone S, Lamberti G. Hydrogel-based commercial products for biomedical applications: a review. Int J Pharm. 2020;573:118803.","journal-title":"Int J Pharm"},{"key":"1253_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular drug delivery: a comprehensive review. AAPS PharmSciTech. 2023;24:66.","journal-title":"AAPS PharmSciTech"},{"key":"1253_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.eurpolymj.2009.04.033","volume":"46","author":"C Chang","year":"2010","unstructured":"Chang C, Duan B, Cai J, Zhang L. Superabsorbent hydrogels based on cellulose for smart swelling and controllable delivery. Eur Polym J. 2010;46:92\u2013100.","journal-title":"Eur Polym J"},{"key":"1253_CR15","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1016\/S0142-9612(02)00175-8","volume":"23","author":"KT Nguyen","year":"2002","unstructured":"Nguyen KT, W JL. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials. 2002;23:4307\u201314.","journal-title":"Biomaterials"},{"key":"1253_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/gels8110706","author":"CBP Oliveira","year":"2022","unstructured":"Oliveira CBP, Gomes V, Ferreira PMT, Martins JA, Jervis PJ. Peptide-based supramolecular hydrogels as drug delivery agents: recent advances. Gels. 2022. https:\/\/doi.org\/10.3390\/gels8110706.","journal-title":"Gels"},{"key":"1253_CR17","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.1039\/C8CS00128F","volume":"47","author":"BH Hu","year":"2018","unstructured":"Hu BH, Owh C, Chee PL, Leow WR, Liu X, Wu YL, et al. Supramolecular hydrogels for antimicrobial therapy. Chem Soc Rev. 2018;47:6917\u201329.","journal-title":"Chem Soc Rev"},{"issue":"7","key":"1253_CR18","first-page":"1019","volume":"6","author":"X Liu","year":"2018","unstructured":"Liu X, Fan XS, Jiang L, Loh XJ, Wu YL, Li ZB, Mater J. Recent developments in thermogelling polymersfor biomedical applications. Mater Chem B. 2018;6(7):1019\u201334.","journal-title":"Mater Chem B."},{"key":"1253_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/gels7040182","volume":"7","author":"M Bustamante-Torres","year":"2021","unstructured":"Bustamante-Torres M, Romero-Fierro D, Arcentales-Vera B, Palomino K, Maga\u00f1a H, Bucio E. Hydrogels classification according to the physical or chemical interactions and as stimuli-sensitive materials. Gels. 2021;7:1\u201325.","journal-title":"Gels"},{"key":"1253_CR20","doi-asserted-by":"crossref","unstructured":"V. Pertici TT, DG. Inputs of macromolecular engineering in the design of injectable hydrogels based on synthetic thermoresponsive polymers Macromol. 2020;53(2):682\u2013692.","DOI":"10.1021\/acs.macromol.9b00705"},{"key":"1253_CR21","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1039\/c3cs35499g","volume":"42","author":"D Roy","year":"2013","unstructured":"Roy D, Brooks WLA, Sumerlin BS. New directions in thermoresponsive polymers. Chem Soc Rev. 2013;42:7214\u201343.","journal-title":"Chem Soc Rev"},{"key":"1253_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1039\/D2PY01097F","volume":"14","author":"AP Constantinou","year":"2022","unstructured":"Constantinou AP, Wang L, Wang S, Georgiou TK. Thermoresponsive block copolymers of increasing architecture complexity: a review on structure-property relationships. Polym Chem. 2022;14:223\u201347.","journal-title":"Polym Chem"},{"key":"1253_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mtchem.2018.02.004","volume":"8","author":"M Mahinroosta","year":"2018","unstructured":"Mahinroosta M, Jomeh Farsangi Z, Allahverdi A, Shakoori Z. Hydrogels as intelligent materials: a brief review of synthesis, properties and applications. Mater Today Chem. 2018;8:42\u201355.","journal-title":"Mater Today Chem"},{"issue":"22","key":"1253_CR24","first-page":"1898","volume":"33","author":"J Seuring","year":"2012","unstructured":"Seuring J, Agarwal S. Polymers with upper critical solution temperature in aqueous solution Macromol Rapid Commun. 2012;33(22):1898\u2013920.","journal-title":"Polymers with upper critical solution temperature in aqueous solution Macromol Rapid Commun."},{"key":"1253_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejpb.2007.02.025","volume":"68","author":"L Klouda","year":"2008","unstructured":"Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm. 2008;68:34\u201345.","journal-title":"Eur J Pharm Biopharm"},{"key":"1253_CR26","doi-asserted-by":"crossref","unstructured":"V. Nele, J. P. Wojciechowski JPKA, Stevens MM. Tailoring gelation mechanisms for advanced hydrogel applications. Adv Funct Mater. 2020;30(42):2002759.","DOI":"10.1002\/adfm.202002759"},{"key":"1253_CR27","doi-asserted-by":"crossref","unstructured":"K. Nishimori M, Maruyama Y, Shimazaki MO, Yoshida H. Design of Thermoresponsive Polymers TowardAntibody Purification. ACS Appl Polym Mater. 2019;1:1925\u20131929.","DOI":"10.1021\/acsapm.9b00137"},{"key":"1253_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijpharm.2005.12.037","volume":"312","author":"S Jamzad","year":"2006","unstructured":"Jamzad S, Fassihi R. Development of a controlled release low dose class II drug-Glipizide. Int J Pharm. 2006;312:24\u201332.","journal-title":"Int J Pharm"},{"key":"1253_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.eurpolymj.2015.03.016","volume":"72","author":"QV Nguyen","year":"2015","unstructured":"Nguyen QV, Huynh DP, Park JH, Lee DS. Injectable polymeric hydrogels for the delivery of therapeutic agents: a review. Eur Polym J. 2015;72:602\u201319.","journal-title":"Eur Polym J"},{"key":"1253_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/0929867311302010009","volume":"20","author":"C Gong","year":"2012","unstructured":"Gong C, Qi T, Wei X, Qu Y, Wu Q, Luo F, et al. Thermosensitive polymeric hydrogels as drug delivery systems. Curr Med Chem. 2012;20:79\u201394.","journal-title":"Curr Med Chem"},{"issue":"11","key":"1253_CR31","first-page":"1433","volume":"70","author":"AP Georgiou","year":"2021","unstructured":"Georgiou AP, Constantinou TK. Thermoresponsive polymers: Structure\u2013property relationships andemerging applications. Polym Int. 2021;70(11):1433\u201348.","journal-title":"Polym Int."},{"key":"1253_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/btm2.10158","volume":"5","author":"A Mandal","year":"2020","unstructured":"Mandal A, Clegg JR, Anselmo AC, Mitragotri S. Hydrogels in the clinic. Bioeng Transl Med. 2020;5:1\u201312.","journal-title":"Bioeng Transl Med"},{"key":"1253_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/btm2.10680","volume":"9","author":"JR Clegg","year":"2024","unstructured":"Clegg JR, Adebowale K, Zhao Z, Mitragotri S. Hydrogels in the clinic: an update. bioeng transl med. 2024;9:1\u201320.","journal-title":"bioeng transl med"},{"key":"1253_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jconrel.2020.07.031","volume":"326","author":"BC Ilochonwu","year":"2020","unstructured":"Ilochonwu BC, Urtti A, Hennink WE, Vermonden T. Intravitreal hydrogels for sustained release of therapeutic proteins. j control release. 2020;326:419\u201341.","journal-title":"j control release"},{"key":"1253_CR35","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","volume":"26","author":"R Gaudana","year":"2009","unstructured":"Gaudana R, Boddu SHS, Jwala J, Mitra AK, Boddu SHS, Mitra AK. Recent perspectives in ocular drug delivery. pharm res. 2009;26:1197\u2013216.","journal-title":"pharm res"},{"key":"1253_CR36","doi-asserted-by":"crossref","unstructured":"Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science. 1991;254(5035):1178\u201381.","DOI":"10.1126\/science.1957169"},{"key":"1253_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/164_2016_32","volume":"242","author":"C Durairaj","year":"2016","unstructured":"Durairaj C. Ocular pharmacokinetics. handb exp pharmacol. 2016;242:31\u201355.","journal-title":"handb exp pharmacol"},{"issue":"6","key":"1253_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","volume":"66","author":"VV Agrahari","year":"2016","unstructured":"Agrahari VV, Mandal A, Agrahari VV, Trinh HM, Joseph M, Ray A, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016;66(6):735\u201354.","journal-title":"Drug Deliv Transl Res"},{"key":"1253_CR39","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1002\/marc.201200433","volume":"33","author":"J Seuring","year":"2012","unstructured":"Seuring J, Agarwal S. Polymers with upper critical solution temperature in aqueous solution. macromol rapid commun. 2012;33:1898\u2013920.","journal-title":"macromol rapid commun"},{"key":"1253_CR40","doi-asserted-by":"publisher","DOI":"10.1039\/c3cs35490c","author":"Z Chu","year":"2013","unstructured":"Chu Z, Dreiss CA, F Y. Smart wormlike micelles. chem soc rev. 2013. https:\/\/doi.org\/10.1039\/c3cs35490c.","journal-title":"chem soc rev"},{"key":"1253_CR41","doi-asserted-by":"crossref","unstructured":"Lai P, Hong D, Ku K. Novel thermosensitive hydrogels based on methoxy polyethylene glycol-co-poly(lactic acid-co-aromatic anhydride) for cefazolin delivery. Nanomedicine. 2014;10(3):553\u2013560","DOI":"10.1016\/j.nano.2013.09.005"},{"key":"1253_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.addr.2012.09.012","volume":"64","author":"B Jeong","year":"2012","unstructured":"Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. adv drug deliv rev. 2012;64:154\u201362.","journal-title":"adv drug deliv rev"},{"key":"1253_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijpharm.2014.06.029","volume":"472","author":"MR Matanovi\u0107","year":"2014","unstructured":"Matanovi\u0107 MR, Kristl J, Grabnar PA. Thermoresponsive polymers: insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications. int j pharm. 2014;472:262\u201375.","journal-title":"int j pharm"},{"key":"1253_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/gels7030077","author":"K Zhang","year":"2021","unstructured":"Zhang K, Xue K, Loh XJ. Thermo-responsive hydrogels: from recent progress to biomedical applications. Gels. 2021. https:\/\/doi.org\/10.3390\/gels7030077.","journal-title":"Gels"},{"key":"1253_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/gels8030167","author":"Z Ahmad","year":"2022","unstructured":"Ahmad Z, Salman S, Khan SASB, Amin A, Rahman ZU, Al-Ghamdi YO, et al. Versatility of hydrogels: from synthetic strategies, classification, and properties to biomedical applications. Gels. 2022. https:\/\/doi.org\/10.3390\/gels8030167.","journal-title":"Gels"},{"key":"1253_CR46","doi-asserted-by":"crossref","unstructured":"Ottenbrite RM, Javan R. Biological structures. In: Bassani GF, Liedl GL, Wyder P, editors. Encyclopedia of condensed matter physics. Oxford: Elsevier; 2005. p. 99\u2013108.","DOI":"10.1016\/B0-12-369401-9\/00698-7"},{"key":"1253_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","volume":"92","author":"CM Caramella","year":"2015","unstructured":"Caramella CM, Rossi S, Ferrari F, Bonferoni MC, Sandri G. Mucoadhesive and thermogelling systems for vaginal drug delivery. Adv Drug Deliv Rev. 2015;92:39\u201352.","journal-title":"Adv Drug Deliv Rev."},{"issue":"5","key":"1253_CR48","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1021\/mz300017y","volume":"1","author":"SH Lahasky","year":"2012","unstructured":"Lahasky SH, Hu X, Zhang D. Thermoresponsive poly(\u03b1-peptoid)s: tuning the cloud point temperatures by composition and architecture. ACS Macro Lett. 2012;1(5):580\u20134.","journal-title":"ACS Macro Lett."},{"key":"1253_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.progpolymsci.2014.10.008","author":"S Strandman","year":"2015","unstructured":"Strandman S, Zhu XX. Thermo-responsive block copolymers with multiple phase transition temperatures in aqueous solutions. Prog Polym Sci. 2015. https:\/\/doi.org\/10.1016\/j.progpolymsci.2014.10.008.","journal-title":"Prog Polym Sci"},{"key":"1253_CR50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.macromol.8b01014","author":"S Cui","year":"2018","unstructured":"Cui S, Yu L, Ding J. Semi-bald micelles and corresponding percolated micelle networks of thermogels. Macromolecules. 2018. https:\/\/doi.org\/10.1021\/acs.macromol.8b01014.","journal-title":"Macromolecules"},{"key":"1253_CR51","doi-asserted-by":"publisher","DOI":"10.1039\/c3tb20901f","author":"X Gao","year":"2013","unstructured":"Gao X, Cao Y, Song X, Zhang Z, Xiao C, He C, et al. pH-and thermo-responsive poly(N-isopropylacrylamide-co-acrylic acid derivative) copolymers and hydrogels with LCST dependent on pH and alkyl side groups. J Mater Chem B. 2013. https:\/\/doi.org\/10.1039\/c3tb20901f.","journal-title":"J Mater Chem B"},{"key":"1253_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2007.02.025","author":"L Knlouda","year":"2008","unstructured":"Knlouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm. 2008. https:\/\/doi.org\/10.1016\/j.ejpb.2007.02.025.","journal-title":"Eur J Pharm Biopharm"},{"key":"1253_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2004.03.019","author":"E Ruel-Gari\u00e9py","year":"2004","unstructured":"Ruel-Gari\u00e9py E, Leroux J-C. In situ-forming hydrogels\u2014review of temperature-sensitive systems. Eur J Pharm Biopharm. 2004. https:\/\/doi.org\/10.1016\/j.ejpb.2004.03.019.","journal-title":"Eur J Pharm Biopharm"},{"key":"1253_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejpb.2007.02.025","volume":"68","author":"L Klouda","year":"2011","unstructured":"Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications - a review. Eur J Pharm Biopharm. 2011;68:34\u201345.","journal-title":"Eur J Pharm Biopharm"},{"key":"1253_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/app.48678","volume":"137","author":"LL Osorno","year":"2020","unstructured":"Osorno LL, Maldonado DE, Whitener RJ, Brandley AN, Yiantsos A, Medina JDR, et al. Amphiphilic PLGA-PEG-PLGA triblock copolymer nanogels varying in gelation temperature and modulus for the extended and controlled release of hyaluronic acid. J Appl Polym Sci. 2020;137:1\u201311.","journal-title":"J Appl Polym Sci"},{"key":"1253_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.08.002","author":"M Hamidi","year":"2008","unstructured":"Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev. 2008. https:\/\/doi.org\/10.1016\/j.addr.2008.08.002.","journal-title":"Adv Drug Deliv Rev"},{"key":"1253_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1163\/156855509X436030","volume":"12","author":"K Pal","year":"2009","unstructured":"Pal K, Banthia AK, Majumdar DK. Polymeric hydrogels: characterization and biomedical applications. Des Monomers Polym. 2009;12:197\u2013220.","journal-title":"Des Monomers Polym"},{"key":"1253_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.polymertesting.2019.106283","volume":"81","author":"Y Sun","year":"2020","unstructured":"Sun Y, Nan D, Jin H, Qu X. Recent advances of injectable hydrogels for drug delivery and tissue engineering applications. Polym Test. 2020;81:106283.","journal-title":"Polym Test"},{"key":"1253_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.reactfunctpolym.2014.07.024","author":"M Constantin","year":"2014","unstructured":"Constantin M, Bucatariu S, Ascenzi P, Simionescu BC, Fundueanu G. Poly (NIPAAm-co-\u03b2-cyclodextrin) microgels with drug hosting and temperature-dependent delivery properties. React Funct Polym. 2014. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2014.07.024.","journal-title":"React Funct Polym"},{"key":"1253_CR60","doi-asserted-by":"crossref","unstructured":"Fassihi R. Capsules. In: Pharmaceutical dosage forms: capsules. Boca Raton (FL): Taylor & Francis Group. 2018. p. 317\u2013344.","DOI":"10.1201\/9781315111896-12"},{"key":"1253_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2014.08.001","author":"EA Appel","year":"2014","unstructured":"Appel EA, Forster RA, Rowland MJ, Scherman OA. The control of cargo release from physically crosslinked hydrogels by crosslink dynamics. Biomaterials. 2014. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.08.001.","journal-title":"Biomaterials"},{"key":"1253_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2013.05.034","author":"X Xu","year":"2013","unstructured":"Xu X, Weng Y, Xu L, Chen H. Sustained release of Avastin(R) from polysaccharides cross-linked hydrogels for ocular drug delivery. Int J Biol Macromol. 2013. https:\/\/doi.org\/10.1016\/j.ijbiomac.2013.05.034.","journal-title":"Int J Biol Macromol"},{"key":"1253_CR63","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/0142-9612(95)00307-X","volume":"17","author":"NASJ Peppas","year":"1996","unstructured":"Peppas NASJ. Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomater Res. 1996;17:1553\u201361.","journal-title":"Biomater Res"},{"key":"1253_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(89)90306-2","author":"NA Peppas","year":"1989","unstructured":"Peppas NA. A simple equation for the description of solute release. III. coupling of diffusion and relaxation. Int J Pharm. 1989. https:\/\/doi.org\/10.1016\/0378-5173(89)90306-2.","journal-title":"Int J Pharm"},{"key":"1253_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics14050998","volume":"14","author":"B Leclercq","year":"2022","unstructured":"Leclercq B, Mejlachowicz D, Behar-Cohen F. Ocular barriers and their influence on gene therapy products delivery. Pharmaceutics. 2022;14:1\u201320.","journal-title":"Pharmaceutics"},{"key":"1253_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11090460","author":"EB Souto","year":"2019","unstructured":"Souto EB, Dias-Ferreira J-M, M. AE, Cano A, Camins EA. Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents. Pharmaceutics. 2019. https:\/\/doi.org\/10.3390\/pharmaceutics11090460.","journal-title":"Pharmaceutics"},{"key":"1253_CR67","doi-asserted-by":"crossref","unstructured":"Nettey H, Darko Y, Bamiro A, Addo RT. Ocular barriers. In: Patel A, editor. Ocular Drug Delivery: Advances, Challenges and Applications. Amsterdam: Elsevier. 2016. p. 31\u201346.","DOI":"10.1007\/978-3-319-47691-9_3"},{"key":"1253_CR68","doi-asserted-by":"publisher","DOI":"10.1533\/9781908818317.1","author":"K Cholkar","year":"2013","unstructured":"Cholkar K, Dasari SR, Pal D, Mitra AK. Eye: anatomy, physiology and barriers to drug delivery. Ocul Transp Recept Their Role Drug Deliv. 2013. https:\/\/doi.org\/10.1533\/9781908818317.1.","journal-title":"Ocul Transp Recept Their Role Drug Deliv"},{"key":"1253_CR69","unstructured":"Centers for Disease Control and Prevention (CDC). Eye Disease Statistics. Atlanta, GA: U.S. Department of Health and Human Services; 2014. Available from: https:\/\/www.cdc.gov\/visionhealth\/basics\/eye-disorders.htm. Accessed 7 Oct. 2025."},{"key":"1253_CR70","unstructured":"Centers for Disease Control and Prevention (CDC). Fast Facts: Vision Loss. May 15, 2024. https:\/\/www.cdc.gov\/vision-health\/data-research\/vision-loss-facts\/index.html. Accessed 13 Oct 2025."},{"key":"1253_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.07.002","author":"H Kaji","year":"2018","unstructured":"Kaji H, Nagai N, Nishizawa M, Abe T. Drug delivery devices for retinal diseases. Adv Drug Deliv Rev. 2018. https:\/\/doi.org\/10.1016\/j.addr.2017.07.002.","journal-title":"Adv Drug Deliv Rev"},{"key":"1253_CR72","unstructured":"CDC. Common Eye Disorders and Diseases. Centers for Disease Control and Prevention; 2025. Available at: https:\/\/www.cdc.gov\/visionhealth\/basics\/eye-disorders.htm. Accessed 13 Oct 2025."},{"key":"1253_CR73","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/17425247.5.5.567","volume":"5","author":"J Barar","year":"2008","unstructured":"Barar J, Javadzadeh AR, Omidi Y. Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv. 2008;5:567\u201381.","journal-title":"Expert Opin Drug Deliv"},{"key":"1253_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2020.00228","volume":"8","author":"CR Lynch","year":"2020","unstructured":"Lynch CR, Kondiah PPD, Choonara YE, du Toit LC, Ally N, Pillay V. Hydrogel biomaterials for application in ocular drug delivery. Front Bioeng Biotechnol. 2020;8:1\u201318.","journal-title":"Front Bioeng Biotechnol"},{"key":"1253_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03719","volume":"6","author":"SH Aswathy","year":"2020","unstructured":"Aswathy SH, Narendrakumar U, Manjubala I. Commercial hydrogels for biomedical applications. Heliyon. 2020;6:e03719.","journal-title":"Heliyon"},{"key":"1253_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/nano9060884","author":"S Sapino","year":"2019","unstructured":"Sapino S, Chirio D, Peira E, Rubio EA, Brunella V, Jadhav SA, et al. Ocular drug delivery: a special focus on the thermosensitive approach. Nanomaterials. 2019. https:\/\/doi.org\/10.3390\/nano9060884.","journal-title":"Nanomaterials"},{"key":"1253_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.02.029","author":"KS Yadav","year":"2019","unstructured":"Yadav KS, Rajpurohit R, Sharma S. Glaucoma: current treatment and impact of advanced drug delivery systems. Life Sci. 2019. https:\/\/doi.org\/10.1016\/j.lfs.2019.02.029.","journal-title":"Life Sci"},{"key":"1253_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm87030015","author":"T Biro","year":"2019","unstructured":"Biro T, Aigner Z. Current approaches to use cyclodextrins and mucoadhesive polymers in ocular drug delivery \u2013 a mini review. Sci Pharm. 2019. https:\/\/doi.org\/10.3390\/scipharm87030015.","journal-title":"Sci Pharm"},{"key":"1253_CR79","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/00914037.2022.2075872","volume":"72","author":"RD Kasai","year":"2023","unstructured":"Kasai RD, Radhika D, Archana S, Shanavaz H, Koutavarapu R, Lee DY, et al. A review on hydrogels classification and recent developments in biomedical applications. Int J Polym Mater Polym Biomater. 2023;72:1059\u201369.","journal-title":"Int J Polym Mater Polym Biomater"},{"issue":"28","key":"1253_CR80","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1039\/C9TB00939F","volume":"7","author":"M Zou","year":"2019","unstructured":"Zou M, Jin R, Hu Y, Zhang Y, Wang H, Liu G, Nie Y, Wang Y. A thermo-sensitive, injectable and biodegradable in situ hydrogel as a potential formulation for uveitis treatment. J Mater Chem B. 2019;7(28):4402\u201312.","journal-title":"J Mater Chem B."},{"key":"1253_CR81","unstructured":"American Society of Retina Specialists (ASRS). Intravitreal Injection. Chicago, IL: American Society of Retina Specialists; 2025. Available from: https:\/\/www.asrs.org\/patients\/retinal-diseases\/33\/intravitreal-injection. Accessed 13 Oct 2025."},{"key":"1253_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091203","author":"KT Lin","year":"2021","unstructured":"Lin KT, Wang A, Nguyen AB, Iyer J, Tran SD. Recent advances in hydrogels: ophthalmic applications in cell delivery, vitreous substitutes, and ocular adhesives. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9091203.","journal-title":"Biomedicines"},{"key":"1253_CR83","unstructured":"Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/ob\/. Accessed 20 Mar 2026."},{"key":"1253_CR84","first-page":"1","volume":"13","author":"HM Kim","year":"2021","unstructured":"Kim HM, Woo SJ. Ocular drug delivery to the retina: current innovations and future perspectives. Pharmaceutics. 2021;13:1\u201332.","journal-title":"Pharmaceutics"},{"key":"1253_CR85","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313462","author":"CW Wong","year":"2019","unstructured":"Wong CW, Wong TT. Posterior segment drug delivery for the treatment of exudative age-related macular degeneration and diabetic macular oedema. Br J Ophthalmol. 2019. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313462.","journal-title":"Br J Ophthalmol"},{"key":"1253_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2014.11.024","author":"E Calo","year":"2015","unstructured":"Calo E, Khutoryanskiy VV. Biomedical applications of hydrogels: a review of patents and commercial products. Eur Polym J. 2015. https:\/\/doi.org\/10.1016\/j.eurpolymj.2014.11.024.","journal-title":"Eur Polym J"},{"issue":"1","key":"1253_CR87","first-page":"7","volume":"5","author":"P Ghasemiyeh","year":"2019","unstructured":"Ghasemiyeh P, Mohammadi-Samani S. Hydrogels as drug delivery systems: pros and cons. Trends Pharm Sci. 2019;5(1):7\u201324.","journal-title":"Trends Pharm Sci."},{"key":"1253_CR88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.addr.2012.09.024","volume":"64","author":"Y Qiu","year":"2012","unstructured":"Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev. 2012;64:49\u201360.","journal-title":"Adv Drug Deliv Rev"},{"key":"1253_CR89","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2020.03.044","volume":"216","author":"R Dana","year":"2020","unstructured":"Dana R, Meunier J, Markowitz JT, Joseph C, Siffel C. Patient-reported burden of Dry Eye Disease in the United States: results of an online cross-sectional survey. Am J Ophthalmol. 2020;216:7\u201317.","journal-title":"Am J Ophthalmol"},{"key":"1253_CR90","unstructured":"American Academy of Ophthalmology (AAO). Dry Eye Disease. San Francisco, CA: American Academy of Ophthalmology; 2024. Available from: https:\/\/www.aao.org\/eye-health\/diseases\/dry-eye. Accessed 13 Oct 2025."},{"key":"1253_CR91","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","volume":"57","author":"A Ludwig","year":"2005","unstructured":"Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57:1595\u2013639.","journal-title":"Adv Drug Deliv Rev"},{"key":"1253_CR92","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.actbio.2023.12.021","volume":"175","author":"L Ou","year":"2024","unstructured":"Ou L, Wu Z, Hu X, Huang J, Yi Z, Gong Z, et al. A tissue-adhesive F127 hydrogel delivers antioxidative copper-selenide nanoparticles for the treatment of dry eye disease. Acta Biomater. 2024;175:353\u201368.","journal-title":"Acta Biomater"},{"key":"1253_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12050993","author":"I De Luca","year":"2023","unstructured":"De Luca I, Di Cristo F, Conte R, Peluso G, Cerruti P, Calarco A. In-situ thermoresponsive hydrogel containing resveratrol-loaded nanoparticles as a localized drug delivery platform for dry eye disease. Antioxidants Basel. 2023. https:\/\/doi.org\/10.3390\/antiox12050993.","journal-title":"Antioxidants Basel"},{"key":"1253_CR94","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2158964","author":"LC Chen","year":"2023","unstructured":"Chen LC, Lin SY, Cheng WJ, Sheu MT, Chung CY, Hsu CH, et al. Poloxamer sols endowed with in-situ gelability and mucoadhesion by adding hypromellose and hyaluronan for prolonging corneal retention and drug delivery. Drug Deliv. 2023. https:\/\/doi.org\/10.1080\/10717544.2022.2158964.","journal-title":"Drug Deliv"},{"key":"1253_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109210","volume":"223","author":"J Luisi","year":"2022","unstructured":"Luisi J, Lin JL, Karediya N, et al. Concentration-associated pathology of alkali burn in a mouse model using anterior segment optical coherence tomography with angiography. Exp Eye Res. 2022;223:109210.","journal-title":"Exp Eye Res"},{"key":"1253_CR96","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47662","author":"M Mittal","year":"2023","unstructured":"Mittal M, Tidake P, Kumar M. Emerging strategies in treating corneal alkali burns: a narrative review. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.47662.","journal-title":"Cureus"},{"key":"1253_CR97","doi-asserted-by":"publisher","unstructured":"de Castro AM, Reis HP, Fernandes C, de Sousa GR, Inoue TT, Fialho LS, et al. Thermoresponsive in-situ gel containing hyaluronic acid and indomethacin for the treatment of corneal chemical burn. Int J Pharm. 2023. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122468.","DOI":"10.1016\/j.ijpharm.2022.122468"},{"key":"1253_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.102108","volume":"54","author":"Q Qin","year":"2024","unstructured":"Qin Q, Chen M, Yu N, Yao K, Liu X, Zhang Q, et al. Macromolecular carrier with long retention and body-temperature triggered nitric oxide release for corneal alkali burn therapy via leptin-related signaling. Nano Today. 2024;54:102108.","journal-title":"Nano Today"},{"key":"1253_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082059","author":"C Zhou","year":"2023","unstructured":"Zhou C, Lei F, Sharma J, Hui PC, Wolkow N, Dohlman CH, et al. Sustained inhibition of VEGF and TNF-\u03b1 achieves multi-ocular protection and prevents formation of blood vessels after severe ocular trauma. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15082059.","journal-title":"Pharmaceutics"},{"key":"1253_CR100","doi-asserted-by":"crossref","unstructured":"Drzyzga \u0141, \u015apiewak D, Dorecka M, Wygl\u0119dowska-Promie\u0144ska D. Available therapeutic options for corneal neovascularization: a review. Int J Mol Sci. 2024;25(10):5479.","DOI":"10.3390\/ijms25105479"},{"key":"1253_CR101","doi-asserted-by":"publisher","first-page":"15","DOI":"10.22336\/rjo.2019.4","volume":"63","author":"Z Sharif","year":"2019","unstructured":"Sharif Z, Sharif W. Corneal neovascularization: updates on pathophysiology, investigations & management. Rom J Ophthalmol. 2019;63:15\u201322.","journal-title":"Rom J Ophthalmol"},{"key":"1253_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.100944","volume":"24","author":"W Nan","year":"2024","unstructured":"Nan W, Shen S, Yang Y, Wu M, He Y, Zhang R, et al. Bone morphogenetic protein 4 thermosensitive hydrogel inhibits corneal neovascularization by repairing corneal epithelial apical junctional complexes. Mater Today Bio. 2024;24:100944.","journal-title":"Mater Today Bio"},{"key":"1253_CR103","doi-asserted-by":"crossref","unstructured":"Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf. 2020;18(4):537\u201344.","DOI":"10.1016\/j.jtos.2020.06.007"},{"key":"1253_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010050","author":"S Xu","year":"2022","unstructured":"Xu S, Ke L, Zhao S, Li Z, Xiao Y, Wu Y, et al. Thermosensitive poly(Dhse\/peg\/ppg urethane)-based hydrogel extended remdesivir application in ophthalmic medication. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14010050.","journal-title":"Pharmaceutics"},{"key":"1253_CR105","unstructured":"Centers for Disease Control and Prevention (CDC). Estimates for Age-Related Macular Degeneration (AMD). Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2022. Available from: https:\/\/www.cdc.gov\/visionhealth\/publications\/amd-estimates.html. Accessed 13 Oct 2025."},{"key":"1253_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/gels10030158","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wang J, Wu H, Fan W, Li S, Wei D, et al. Hydrogel-based therapy for age-related macular degeneration: current innovations, impediments, and future perspectives. Gels. 2024. https:\/\/doi.org\/10.3390\/gels10030158.","journal-title":"Gels"},{"key":"1253_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00265-2","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, et al. Age-related macular degeneration. Nat Rev Dis Prim. 2021. https:\/\/doi.org\/10.1038\/s41572-021-00265-2.","journal-title":"Nat Rev Dis Prim"},{"key":"1253_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/gels12020105","volume":"12","author":"W Zhu","year":"2026","unstructured":"Zhu W, Xia M, He Y, Huang Q, Liao Z, Wang X, et al. Hydrogels as promising carriers for ophthalmic disease treatment: A comprehensive review. Gels. 2026;12:1\u201328.","journal-title":"Gels"},{"key":"1253_CR109","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.2147\/DDDT.S383101","volume":"16","author":"M Xu","year":"2022","unstructured":"Xu M, Fan R, Fan X, Shao Y, Li X. Progress and challenges of anti-VEGF agents and their sustained-release strategies for retinal angiogenesis. Drug Des Devel Ther. 2022;16:3241\u201362.","journal-title":"Drug Des Devel Ther"},{"key":"1253_CR110","first-page":"1","volume":"35","author":"H Gao","year":"2023","unstructured":"Gao H, Chen M, Liu Y, et al. Injectable anti-inflammatory supramolecular nanofiber hydrogel to promote Anti-VEGF therapy in age-related macular degeneration treatment. Adv Mater. 2023;35:1\u201312.","journal-title":"Adv Mater"},{"key":"1253_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-023-01829-y","volume":"21","author":"W Su","year":"2023","unstructured":"Su W, Liu C, Jiang X, et al. An intravitreal-injectable hydrogel depot doped borneol-decorated dual-drug-coloaded microemulsions for long-lasting retina delivery and synergistic therapy of wAMD. J Nanobiotechnol. 2023;21:1\u201319.","journal-title":"J Nanobiotechnol"},{"key":"1253_CR112","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jconrel.2023.07.052","volume":"361","author":"BC Ilochonwu","year":"2023","unstructured":"Ilochonwu BC, van der Lugt SA, Annala A, Di Marco G, Sampon T, Siepmann J, et al. Thermo-responsive Diels-Alder stabilized hydrogels for ocular drug delivery of a corticosteroid and an anti-VEGF fab fragment. J Control Release. 2023;361:334\u201349.","journal-title":"J Control Release"},{"key":"1253_CR113","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1021\/acspolymersau.2c00038","volume":"3","author":"A Annala","year":"2023","unstructured":"Annala A, Ilochonwu BC, Wilbie D, Sadeghi A, Hennink WE, Vermonden T. Self-healing thermosensitive hydrogel for sustained release of dexamethasone for ocular therapy. ACS Polym Au. 2023;3:118\u201331.","journal-title":"ACS Polym Au"},{"key":"1253_CR114","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00109-013-0993-5","volume":"91","author":"PA Campochiaro","year":"2013","unstructured":"Campochiaro PA. Ocular neovascularization. J Mol Med (Berl). 2013;91:311\u201321.","journal-title":"J Mol Med (Berl)"},{"key":"1253_CR115","doi-asserted-by":"crossref","unstructured":"Mitchell B, Max MD, Sue A, Lynch MD, Joanne Muir RN, MS, Shoaf SE, Smoller B, Dubner R. The New England journal of medicine is produced by NEJM Group, a division of the Massachusetts Medical Society. Downloaded from nejm.org on October 20, 2025. Copyright \u00a9 1992 Massachusetts Medical Society. All rights reserved, including those for text and. N Engl J Med 1992;326:1250\u20131256.","DOI":"10.1056\/NEJM199205073261904"},{"key":"1253_CR116","doi-asserted-by":"publisher","first-page":"17531","DOI":"10.1021\/acsomega.0c02009","volume":"5","author":"K Dutta","year":"2020","unstructured":"Dutta K, Das R, Ling J, et al. In situ forming injectable thermoresponsive hydrogels for controlled delivery of biomacromolecules. ACS Omega. 2020;5:17531\u201342.","journal-title":"ACS Omega"},{"key":"1253_CR117","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1167\/iovs.13-13120","volume":"55","author":"BM Rauck","year":"2013","unstructured":"Rauck BM, Friberg TR, Medina Mendez CA, Park D, Shah V, Bilonick RA, et al. Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo. Investig Ophthalmol Vis Sci. 2013;55:469\u201370.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1253_CR118","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1021\/acsami.2c17626","volume":"15","author":"N Duan","year":"2023","unstructured":"Duan N, Mei L, Hu L, Yin X, Wei X, Li Y, et al. Biomimetic, injectable, and self-healing hydrogels with sustained release of Ranibizumab to treat retinal neovascularization. ACS Appl Mater Interfaces. 2023;15:6371\u201384.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1253_CR119","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11686","author":"K Allison","year":"2020","unstructured":"Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020. https:\/\/doi.org\/10.7759\/cureus.11686.","journal-title":"Cureus"},{"key":"1253_CR120","unstructured":"CDC. Glaucoma. Centers for Disease Control and Prevention; 2024. Available from: https:\/\/www.cdc.gov\/visionhealth\/glaucoma.htm. Accessed 13 Oct 2025."},{"key":"1253_CR121","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijbiomac.2020.04.274","volume":"159","author":"Y Pakzad","year":"2020","unstructured":"Pakzad Y, Fathi M, Omidi Y, Mozafari M, Zamanian A. Synthesis and characterization of timolol maleate-loaded quaternized chitosan-based thermosensitive hydrogel: a transparent topical ocular delivery system for the treatment of glaucoma. Int J Biol Macromol. 2020;159:117\u201328.","journal-title":"Int J Biol Macromol"},{"key":"1253_CR122","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exer.2018.11.017","volume":"179","author":"YH Cheng","year":"2019","unstructured":"Cheng YH, Ko YC, Chang YF, Huang SH, Liu C. Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment. Exp Eye Res. 2019;179:179\u201387.","journal-title":"Exp Eye Res"},{"key":"1253_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.reactfunctpolym.2018.01.001","author":"A Prasannan","year":"2018","unstructured":"Prasannan A, Tsai HC, Hsiue GH. Formulation and evaluation of epinephrine-loaded poly(acrylic acid-co-N-isopropylacrylamide) gel for sustained ophthalmic drug delivery. React Funct Polym. 2018. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2018.01.001.","journal-title":"React Funct Polym"},{"key":"1253_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-09379-8","volume":"7","author":"MV Fedorchak","year":"2017","unstructured":"Fedorchak MV, Conner IP, Schuman JS, Cugini A, Little SR. Long term glaucoma drug delivery using a topically retained gel\/microsphere eye drop. Sci Rep. 2017;7:1\u201311.","journal-title":"Sci Rep"},{"key":"1253_CR125","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","volume":"26","author":"R Gaudana","year":"2009","unstructured":"Gaudana R, Boddu SHS, Jwala J, Mitra AK. Recent perspectives in ocular drug delivery Ripal. Pharm Res. 2009;26:1197\u2013216.","journal-title":"Pharm Res"},{"key":"1253_CR126","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","volume":"57","author":"EM del Amo","year":"2017","unstructured":"del Amo EM, Rimpel\u00e4 AK, Heikkinen E, et al. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2017;57:134\u201385.","journal-title":"Prog Retin Eye Res"},{"key":"1253_CR127","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178\u201381 ((80- )).","journal-title":"Science"},{"key":"1253_CR128","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1007\/s11095-012-0721-9","volume":"29","author":"PJ Missel","year":"2012","unstructured":"Missel PJ. Simulating intravitreal injections in anatomically accurate models for rabbit, monkey, and human eyes. Pharm Res. 2012;29:3251\u201372.","journal-title":"Pharm Res"},{"key":"1253_CR129","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1248\/cpb.52.1290","volume":"52","author":"K Tojo","year":"2004","unstructured":"Tojo K. A pharmacokinetic model for ocular drug delivery. Chem Pharm Bull. 2004;52:1290\u20134.","journal-title":"Chem Pharm Bull"},{"key":"1253_CR130","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","volume":"49","author":"TR Hoare","year":"2008","unstructured":"Hoare TR, Kohane DS. Hydrogels in drug delivery: progress and challenges. Polymer (Guildf). 2008;49:1993\u20132007.","journal-title":"Polymer (Guildf)"},{"key":"1253_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.71","volume":"1","author":"J Li","year":"2016","unstructured":"Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nat Rev Mater. 2016;1:16071-.","journal-title":"Nat Rev Mater"},{"key":"1253_CR132","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejpb.2020.05.005","volume":"153","author":"S Awwad","year":"2020","unstructured":"Awwad S, Henein C, Ibeanu N, Khaw PT, Brocchini S. Preclinical challenges for developing long acting intravitreal medicines. Eur J Pharm Biopharm. 2020;153:130\u201349.","journal-title":"Eur J Pharm Biopharm"},{"key":"1253_CR133","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.4.2.5","volume":"4","author":"Y Yu","year":"2015","unstructured":"Yu Y, Lau LCM, Lo AC, Chau Y. Injectable chemically crosslinked hydrogel for the controlled release of Bevacizumab in vitreous: a 6-month in vivo study. Transl Vis Sci Technol. 2015;4:5.","journal-title":"Transl Vis Sci Technol"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01253-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01253-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01253-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:03:07Z","timestamp":1779807787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01253-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":133,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01253-8","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of the manuscript have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"104"}}